Donna L. Lewand

408 total citations
17 papers, 328 citations indexed

About

Donna L. Lewand is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Oncology. According to data from OpenAlex, Donna L. Lewand has authored 17 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Health, Toxicology and Mutagenesis and 4 papers in Oncology. Recurrent topics in Donna L. Lewand's work include Heavy Metal Exposure and Toxicity (6 papers), Ion Transport and Channel Regulation (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Donna L. Lewand is often cited by papers focused on Heavy Metal Exposure and Toxicity (6 papers), Ion Transport and Channel Regulation (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Donna L. Lewand collaborates with scholars based in United States. Donna L. Lewand's co-authors include Samuel S. Blumenthal, Ann M. Beshensky, Elaine M. Worcester, David H. Petering, E. J. Tapper, Niloofar M. Tabatabai, Alan S. Bloom, Jack G. Kleinman, Gretchen S. Mandel and Neil S. Mandel and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Donna L. Lewand

17 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna L. Lewand United States 11 138 74 71 70 64 17 328
Henry A. Peters United States 13 231 1.7× 36 0.5× 49 0.7× 92 1.3× 24 0.4× 19 574
H Wagner Germany 10 107 0.8× 38 0.5× 24 0.3× 68 1.0× 22 0.3× 30 359
Kyoko Hosokawa Japan 12 90 0.7× 13 0.2× 70 1.0× 44 0.6× 29 0.5× 34 340
C. J. Robinson United Kingdom 12 148 1.1× 25 0.3× 42 0.6× 14 0.2× 58 0.9× 18 490
H. G. Haas Switzerland 11 140 1.0× 60 0.8× 73 1.0× 11 0.2× 44 0.7× 42 518
Tingting Mo China 12 109 0.8× 25 0.3× 56 0.8× 96 1.4× 59 0.9× 34 457
Zhonglin Cai China 14 187 1.4× 23 0.3× 45 0.6× 62 0.9× 69 1.1× 35 542
Füsun Öztay Türkiye 15 145 1.1× 25 0.3× 175 2.5× 25 0.4× 32 0.5× 35 486
Giuseppe Minniti Italy 10 91 0.7× 125 1.7× 23 0.3× 30 0.4× 54 0.8× 22 398
Kiyoshi Omura Japan 12 165 1.2× 53 0.7× 8 0.1× 42 0.6× 79 1.2× 38 482

Countries citing papers authored by Donna L. Lewand

Since Specialization
Citations

This map shows the geographic impact of Donna L. Lewand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna L. Lewand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna L. Lewand more than expected).

Fields of papers citing papers by Donna L. Lewand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna L. Lewand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna L. Lewand. The network helps show where Donna L. Lewand may publish in the future.

Co-authorship network of co-authors of Donna L. Lewand

This figure shows the co-authorship network connecting the top 25 collaborators of Donna L. Lewand. A scholar is included among the top collaborators of Donna L. Lewand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna L. Lewand. Donna L. Lewand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tabatabai, Niloofar M., Samuel S. Blumenthal, Donna L. Lewand, & David H. Petering. (2003). Mouse kidney expresses mRNA of four highly related sodium-glucose cotransporters: Regulation by cadmium. Kidney International. 64(4). 1320–1330. 22 indexed citations
2.
Tabatabai, Niloofar M., Samuel S. Blumenthal, Donna L. Lewand, & David H. Petering. (2001). Differential Regulation of Mouse Kidney Sodium-Dependent Transporters mRNA by Cadmium. Toxicology and Applied Pharmacology. 177(3). 163–173. 28 indexed citations
3.
Blumenthal, Samuel S., et al.. (1998). Cadmium Decreases SGLT1 Messenger RNA in Mouse Kidney Cells. Toxicology and Applied Pharmacology. 149(1). 49–54. 15 indexed citations
4.
Blumenthal, Samuel S., et al.. (1996). Comparative Effects of Cd2+and Cd–Metallothionein on Cultured Kidney Tubule Cells. Toxicology and Applied Pharmacology. 136(2). 220–228. 12 indexed citations
5.
Blumenthal, Samuel S., et al.. (1995). Effect of serum proteins on sodium-linked transport processes in cultured kidney cells.. Journal of the American Society of Nephrology. 5(11). 1964–1970. 2 indexed citations
6.
Blumenthal, Samuel S., Donna L. Lewand, Aleksander Sochanik, Susan Krezoski, & David H. Petering. (1994). Inhibition of Na+-Glucose Cotransport in Kidney Cortical Cells by Cadmium and Copper: Protection by Zinc. Toxicology and Applied Pharmacology. 129(2). 177–187. 15 indexed citations
7.
Worcester, Elaine M., Samuel S. Blumenthal, Ann M. Beshensky, & Donna L. Lewand. (1992). The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. Journal of Bone and Mineral Research. 7(9). 1029–1036. 112 indexed citations
8.
Blumenthal, Samuel S., et al.. (1990). Cadmium inhibits glucose uptake in primary cultures of mouse cortical tubule cells. American Journal of Physiology-Renal Physiology. 258(6). F1625–F1633. 18 indexed citations
9.
Blumenthal, Samuel S., et al.. (1989). Effect of pH on growth of mouse renal cortical tubule cells in primary culture. American Journal of Physiology-Cell Physiology. 257(3). C419–C426. 12 indexed citations
10.
Kleinman, Jack G., Samuel S. Blumenthal, John H. Wiessner, et al.. (1987). Regulation of pH in rat papillary tubule cells in primary culture.. Journal of Clinical Investigation. 80(6). 1660–1669. 27 indexed citations
11.
Ammon, Helmut V., et al.. (1985). Effects of sulfodeoxycholate on rat and rabbit small intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 248(4). G485–G493. 7 indexed citations
12.
Tapper, E. J., Alan S. Bloom, & Donna L. Lewand. (1981). Endogenous norepinephrine release induced by tyramine modulates intestinal ion transport. American Journal of Physiology-Gastrointestinal and Liver Physiology. 241(3). G264–G269. 29 indexed citations
13.
Tapper, E. J. & Donna L. Lewand. (1981). Actions of a nicotinic agonist, DMPP, on intestinal ion transport. Life Sciences. 28(2). 155–162. 12 indexed citations
14.
Lewand, Donna L., et al.. (1977). Detection of benzoylecgonine in human urine. Journal of Chromatography A. 144(1). 101–107. 1 indexed citations
15.
Roerig, David L., et al.. (1976). Radioimmunuassay compared to thin-layer and gas--liquid chromatography for detecting methadone in human urine.. Clinical Chemistry. 22(11). 1915–1918. 4 indexed citations
16.
Roerig, David L., et al.. (1975). Methods of identification and confirmation of abusive drugs in human urine. Journal of Chromatography A. 110(2). 349–359. 9 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026